ID   AT11A_HUMAN             Reviewed;        1134 AA.
AC   P98196; Q5VXT2;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   24-JAN-2006, sequence version 3.
DT   12-APR-2017, entry version 155.
DE   RecName: Full=Probable phospholipid-transporting ATPase IH;
DE            EC=3.6.3.1;
DE   AltName: Full=ATPase IS;
DE   AltName: Full=ATPase class VI type 11A;
DE   AltName: Full=P4-ATPase flippase complex alpha subunit ATP11A;
GN   Name=ATP11A; Synonyms=ATPIH, ATPIS, KIAA1021;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057823; DOI=10.1038/nature02379;
RA   Dunham A., Matthews L.H., Burton J., Ashurst J.L., Howe K.L.,
RA   Ashcroft K.J., Beare D.M., Burford D.C., Hunt S.E.,
RA   Griffiths-Jones S., Jones M.C., Keenan S.J., Oliver K., Scott C.E.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Andrews D.T.,
RA   Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J., Bannerjee R.,
RA   Barlow K.F., Bates K., Beasley H., Bird C.P., Bray-Allen S.,
RA   Brown A.J., Brown J.Y., Burrill W., Carder C., Carter N.P.,
RA   Chapman J.C., Clamp M.E., Clark S.Y., Clarke G., Clee C.M.,
RA   Clegg S.C., Cobley V., Collins J.E., Corby N., Coville G.J.,
RA   Deloukas P., Dhami P., Dunham I., Dunn M., Earthrowl M.E.,
RA   Ellington A.G., Faulkner L., Frankish A.G., Frankland J., French L.,
RA   Garner P., Garnett J., Gilbert J.G.R., Gilson C.J., Ghori J.,
RA   Grafham D.V., Gribble S.M., Griffiths C., Hall R.E., Hammond S.,
RA   Harley J.L., Hart E.A., Heath P.D., Howden P.J., Huckle E.J.,
RA   Hunt P.J., Hunt A.R., Johnson C., Johnson D., Kay M., Kimberley A.M.,
RA   King A., Laird G.K., Langford C.J., Lawlor S., Leongamornlert D.A.,
RA   Lloyd D.M., Lloyd C., Loveland J.E., Lovell J., Martin S.,
RA   Mashreghi-Mohammadi M., McLaren S.J., McMurray A., Milne S.,
RA   Moore M.J.F., Nickerson T., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K.M., Rice C.M., Searle S.,
RA   Sehra H.K., Shownkeen R., Skuce C.D., Smith M., Steward C.A.,
RA   Sycamore N., Tester J., Thomas D.W., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., Whitehead S.L., Willey D.L.,
RA   Wilming L., Wray P.W., Wright M.W., Young L., Coulson A., Durbin R.M.,
RA   Hubbard T., Sulston J.E., Beck S., Bentley D.R., Rogers J., Ross M.T.;
RT   "The DNA sequence and analysis of human chromosome 13.";
RL   Nature 428:522-528(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 33-1134, AND VARIANT
RP   VAL-317.
RC   TISSUE=Brain;
RX   PubMed=10470851; DOI=10.1093/dnares/6.3.197;
RA   Kikuno R., Nagase T., Ishikawa K., Hirosawa M., Miyajima N.,
RA   Tanaka A., Kotani H., Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XIV.
RT   The complete sequences of 100 new cDNA clones from brain which code
RT   for large proteins in vitro.";
RL   DNA Res. 6:197-205(1999).
RN   [3]
RP   SEQUENCE REVISION.
RA   Ohara O., Nagase T., Kikuno R.;
RL   Submitted (AUG-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   FUNCTION.
RX   PubMed=15860663; DOI=10.1182/blood-2004-09-3655;
RA   Zhang B., Groffen J., Heisterkamp N.;
RT   "Resistance to farnesyltransferase inhibitors in Bcr/Abl-positive
RT   lymphoblastic leukemia by increased expression of a novel ABC
RT   transporter homolog ATP11a.";
RL   Blood 106:1355-1361(2005).
RN   [5]
RP   INTERACTION WITH TMEM30A, AND SUBCELLULAR LOCATION.
RX   PubMed=21914794; DOI=10.1074/jbc.M111.281006;
RA   Takatsu H., Baba K., Shima T., Umino H., Kato U., Umeda M.,
RA   Nakayama K., Shin H.W.;
RT   "ATP9B, a P4-ATPase (a putative aminophospholipid translocase),
RT   localizes to the trans-Golgi network in a CDC50 protein-independent
RT   manner.";
RL   J. Biol. Chem. 286:38159-38167(2011).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-738, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
CC   -!- FUNCTION: Catalytic component of a P4-ATPase flippase complex
CC       which catalyzes the hydrolysis of ATP coupled to the transport of
CC       aminophospholipids from the outer to the inner leaflet of various
CC       membranes and ensures the maintenance of asymmetric distribution
CC       of phospholipids. Phospholipid translocation seems also to be
CC       implicated in vesicle formation and in uptake of lipid signaling
CC       molecules (Probable). May be involved in the uptake of
CC       farnesyltransferase inhibitor drugs, such as lonafarnib.
CC       {ECO:0000269|PubMed:15860663, ECO:0000305}.
CC   -!- CATALYTIC ACTIVITY: ATP + H(2)O + phospholipid(Side 1) = ADP +
CC       phosphate + phospholipid(Side 2).
CC   -!- SUBUNIT: Component of a P4-ATPase flippase complex which consists
CC       of a catalytic alpha subunit and an accessory beta subunit
CC       (Probable). Interacts with beta subunit TMEM30A.
CC       {ECO:0000269|PubMed:21914794, ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:21914794};
CC       Multi-pass membrane protein {ECO:0000269|PubMed:21914794}. Early
CC       endosome {ECO:0000269|PubMed:21914794}. Recycling endosome
CC       {ECO:0000269|PubMed:21914794}. Endoplasmic reticulum
CC       {ECO:0000269|PubMed:21914794}. Note=Exit from the endoplasmic
CC       reticulum requires the presence of TMEM30A, but not TMEM30B. In
CC       the presence of TMEM30A, predominantly located in the plasma
CC       membrane.
CC   -!- MISCELLANEOUS: Overexpression of ATP11A confers resistance to
CC       lonafarnib.
CC   -!- SIMILARITY: Belongs to the cation transport ATPase (P-type)
CC       (TC 3.A.3) family. Type IV subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AL356740; CAH70242.1; -; Genomic_DNA.
DR   EMBL; AL139384; CAH70242.1; JOINED; Genomic_DNA.
DR   EMBL; AL356752; CAH70242.1; JOINED; Genomic_DNA.
DR   EMBL; AL139384; CAI16947.1; -; Genomic_DNA.
DR   EMBL; AL356740; CAI16947.1; JOINED; Genomic_DNA.
DR   EMBL; AL356752; CAI16947.1; JOINED; Genomic_DNA.
DR   EMBL; AL356752; CAI16578.1; -; Genomic_DNA.
DR   EMBL; AL356740; CAI16578.1; JOINED; Genomic_DNA.
DR   EMBL; AL139384; CAI16578.1; JOINED; Genomic_DNA.
DR   EMBL; AB028944; BAA82973.2; -; mRNA.
DR   CCDS; CCDS32011.1; -.
DR   RefSeq; NP_056020.2; NM_015205.2.
DR   RefSeq; NP_115565.3; NM_032189.3.
DR   RefSeq; XP_005268362.1; XM_005268305.4.
DR   RefSeq; XP_005268363.1; XM_005268306.4.
DR   RefSeq; XP_016875981.1; XM_017020492.1.
DR   UniGene; Hs.29189; -.
DR   ProteinModelPortal; P98196; -.
DR   BioGrid; 116854; 3.
DR   MINT; MINT-5004429; -.
DR   STRING; 9606.ENSP00000283558; -.
DR   TCDB; 3.A.3.8.17; the p-type atpase (p-atpase) superfamily.
DR   iPTMnet; P98196; -.
DR   PhosphoSitePlus; P98196; -.
DR   SwissPalm; P98196; -.
DR   BioMuta; ATP11A; -.
DR   DMDM; 85700404; -.
DR   EPD; P98196; -.
DR   MaxQB; P98196; -.
DR   PaxDb; P98196; -.
DR   PeptideAtlas; P98196; -.
DR   PRIDE; P98196; -.
DR   DNASU; 23250; -.
DR   Ensembl; ENST00000375645; ENSP00000364796; ENSG00000068650.
DR   Ensembl; ENST00000487903; ENSP00000420387; ENSG00000068650.
DR   GeneID; 23250; -.
DR   KEGG; hsa:23250; -.
DR   UCSC; uc001vsi.4; human.
DR   CTD; 23250; -.
DR   DisGeNET; 23250; -.
DR   GeneCards; ATP11A; -.
DR   HGNC; HGNC:13552; ATP11A.
DR   HPA; HPA035583; -.
DR   HPA; HPA035584; -.
DR   MalaCards; ATP11A; -.
DR   MIM; 605868; gene.
DR   neXtProt; NX_P98196; -.
DR   OpenTargets; ENSG00000068650; -.
DR   Orphanet; 2032; Idiopathic pulmonary fibrosis.
DR   PharmGKB; PA25101; -.
DR   eggNOG; KOG0206; Eukaryota.
DR   eggNOG; COG0474; LUCA.
DR   GeneTree; ENSGT00870000136387; -.
DR   HOGENOM; HOG000202528; -.
DR   HOVERGEN; HBG050601; -.
DR   InParanoid; P98196; -.
DR   KO; K01530; -.
DR   PhylomeDB; P98196; -.
DR   TreeFam; TF326897; -.
DR   Reactome; R-HSA-6798695; Neutrophil degranulation.
DR   Reactome; R-HSA-936837; Ion transport by P-type ATPases.
DR   ChiTaRS; ATP11A; human.
DR   GenomeRNAi; 23250; -.
DR   PRO; PR:P98196; -.
DR   Proteomes; UP000005640; Chromosome 13.
DR   Bgee; ENSG00000068650; -.
DR   CleanEx; HS_ATP11A; -.
DR   ExpressionAtlas; P98196; baseline and differential.
DR   Genevisible; P98196; HS.
DR   GO; GO:0005769; C:early endosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:UniProtKB.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
DR   GO; GO:0005765; C:lysosomal membrane; IDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0055037; C:recycling endosome; IDA:UniProtKB.
DR   GO; GO:0035579; C:specific granule membrane; TAS:Reactome.
DR   GO; GO:0070821; C:tertiary granule membrane; TAS:Reactome.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0000287; F:magnesium ion binding; IEA:InterPro.
DR   GO; GO:0004012; F:phospholipid-translocating ATPase activity; IBA:GO_Central.
DR   GO; GO:0043312; P:neutrophil degranulation; TAS:Reactome.
DR   GO; GO:0045332; P:phospholipid translocation; NAS:UniProtKB.
DR   Gene3D; 2.70.150.10; -; 1.
DR   Gene3D; 3.40.1110.10; -; 1.
DR   Gene3D; 3.40.50.1000; -; 1.
DR   InterPro; IPR030361; ATP11A.
DR   InterPro; IPR023299; ATPase_P-typ_cyto_domN.
DR   InterPro; IPR018303; ATPase_P-typ_P_site.
DR   InterPro; IPR008250; ATPase_P-typ_transduc_dom_A.
DR   InterPro; IPR023214; HAD-like_dom.
DR   InterPro; IPR006539; P-type_ATPase_IV.
DR   InterPro; IPR032631; P-type_ATPase_N.
DR   InterPro; IPR001757; P_typ_ATPase.
DR   InterPro; IPR032630; P_typ_ATPase_c.
DR   PANTHER; PTHR24092; PTHR24092; 1.
DR   PANTHER; PTHR24092:SF124; PTHR24092:SF124; 1.
DR   Pfam; PF00122; E1-E2_ATPase; 1.
DR   Pfam; PF16212; PhoLip_ATPase_C; 1.
DR   Pfam; PF16209; PhoLip_ATPase_N; 1.
DR   SUPFAM; SSF56784; SSF56784; 3.
DR   SUPFAM; SSF81660; SSF81660; 1.
DR   TIGRFAMs; TIGR01652; ATPase-Plipid; 1.
DR   TIGRFAMs; TIGR01494; ATPase_P-type; 3.
DR   PROSITE; PS00154; ATPASE_E1_E2; 1.
PE   1: Evidence at protein level;
KW   ATP-binding; Cell membrane; Complete proteome; Endoplasmic reticulum;
KW   Endosome; Hydrolase; Lipid transport; Magnesium; Membrane;
KW   Metal-binding; Nucleotide-binding; Phosphoprotein; Polymorphism;
KW   Reference proteome; Transmembrane; Transmembrane helix; Transport.
FT   CHAIN         1   1134       Probable phospholipid-transporting ATPase
FT                                IH.
FT                                /FTId=PRO_0000046369.
FT   TOPO_DOM      1     61       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     62     82       Helical. {ECO:0000255}.
FT   TOPO_DOM     83     88       Extracellular. {ECO:0000255}.
FT   TRANSMEM     89    110       Helical. {ECO:0000255}.
FT   TOPO_DOM    111    296       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    297    318       Helical. {ECO:0000255}.
FT   TOPO_DOM    319    349       Extracellular. {ECO:0000255}.
FT   TRANSMEM    350    372       Helical. {ECO:0000255}.
FT   TOPO_DOM    373    881       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    882    902       Helical. {ECO:0000255}.
FT   TOPO_DOM    903    914       Extracellular. {ECO:0000255}.
FT   TRANSMEM    915    934       Helical. {ECO:0000255}.
FT   TOPO_DOM    935    964       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    965    986       Helical. {ECO:0000255}.
FT   TOPO_DOM    987   1000       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1001   1023       Helical. {ECO:0000255}.
FT   TOPO_DOM   1024   1029       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1030   1050       Helical. {ECO:0000255}.
FT   TOPO_DOM   1051   1068       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1069   1093       Helical. {ECO:0000255}.
FT   TOPO_DOM   1094   1134       Cytoplasmic. {ECO:0000255}.
FT   ACT_SITE    414    414       4-aspartylphosphate intermediate.
FT                                {ECO:0000250}.
FT   METAL       825    825       Magnesium. {ECO:0000250}.
FT   METAL       829    829       Magnesium. {ECO:0000250}.
FT   MOD_RES     738    738       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   VARIANT     317    317       M -> V (in dbSNP:rs368865).
FT                                {ECO:0000269|PubMed:10470851}.
FT                                /FTId=VAR_059139.
FT   VARIANT    1091   1091       V -> I (in dbSNP:rs11616795).
FT                                /FTId=VAR_048379.
SQ   SEQUENCE   1134 AA;  129756 MW;  A486BDFC85D6D3B2 CRC64;
     MDCSLVRTLV HRYCAGEENW VDSRTIYVGH REPPPGAEAY IPQRYPDNRI VSSKYTFWNF
     IPKNLFEQFR RVANFYFLII FLVQLIIDTP TSPVTSGLPL FFVITVTAIK QGYEDWLRHK
     ADNAMNQCPV HFIQHGKLVR KQSRKLRVGD IVMVKEDETF PCDLIFLSSN RGDGTCHVTT
     ASLDGESSHK THYAVQDTKG FHTEEDIGGL HATIECEQPQ PDLYKFVGRI NVYSDLNDPV
     VRPLGSENLL LRGATLKNTE KIFGVAIYTG METKMALNYQ SKSQKRSAVE KSMNAFLIVY
     LCILISKALI NTVLKYMWQS EPFRDEPWYN QKTESERQRN LFLKAFTDFL AFMVLFNYII
     PVSMYVTVEM QKFLGSYFIT WDEDMFDEET GEGPLVNTSD LNEELGQVEY IFTDKTGTLT
     ENNMEFKECC IEGHVYVPHV ICNGQVLPES SGIDMIDSSP SVNGREREEL FFRALCLCHT
     VQVKDDDSVD GPRKSPDGGK SCVYISSSPD EVALVEGVQR LGFTYLRLKD NYMEILNREN
     HIERFELLEI LSFDSVRRRM SVIVKSATGE IYLFCKGADS SIFPRVIEGK VDQIRARVER
     NAVEGLRTLC VAYKRLIQEE YEGICKLLQA AKVALQDREK KLAEAYEQIE KDLTLLGATA
     VEDRLQEKAA DTIEALQKAG IKVWVLTGDK METAAATCYA CKLFRRNTQL LELTTKRIEE
     QSLHDVLFEL SKTVLRHSGS LTRDNLSGLS ADMQDYGLII DGAALSLIMK PREDGSSGNY
     RELFLEICRS CSAVLCCRMA PLQKAQIVKL IKFSKEHPIT LAIGDGANDV SMILEAHVGI
     GVIGKEGRQA ARNSDYAIPK FKHLKKMLLV HGHFYYIRIS ELVQYFFYKN VCFIFPQFLY
     QFFCGFSQQT LYDTAYLTLY NISFTSLPIL LYSLMEQHVG IDVLKRDPTL YRDVAKNALL
     RWRVFIYWTL LGLFDALVFF FGAYFVFENT TVTSNGQIFG NWTFGTLVFT VMVFTVTLKL
     ALDTHYWTWI NHFVIWGSLL FYVVFSLLWG GVIWPFLNYQ RMYYVFIQML SSGPAWLAIV
     LLVTISLLPD VLKKVLCRQL WPTATERVQT KSQCLSVEQS TIFMLSQTSS SLSF
//
